Prolactin and antipsychotic medications: mechanism of action
Open Access
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 35, S67-S73
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Attenuation of Antipsychotic-Induced Hyperprolactinemia with ClozapineJournal of Child and Adolescent Psychopharmacology, 1997
- ICI 204,636, an Atypical AntipsychoticJournal of Clinical Psychopharmacology, 1996
- Effect of Clozapine on d-Fenfluramine-Evoked Neuroendocrine Responses in Schizophrenia and its Relationship to Clinical ImprovementThe British Journal of Psychiatry, 1995
- The effect of clozapine on prolactin secretion at the level of the lactotrophLife Sciences, 1990
- Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsPsychopharmacology, 1989
- Neuroleptics and Neuroendocrine FunctionAnnual Review of Pharmacology and Toxicology, 1988
- Role of estrogens on striatal dopaminergic activityJournal of Steroid Biochemistry, 1987
- Effect of Bromocriptine Mesylate on Induced Hyperprolactinemia in Stabilized Psychiatric Outpatients Undergoing Neuroleptic TreatmentNeuropsychobiology, 1985
- Lack of tolerance to long‐term neuroleptic treatment in dopamine tuberoinfundibular systemActa Psychiatrica Scandinavica, 1981
- MECHANISM OF INCREASED PROLACTIN SECRETION BY SULPIRIDEJournal of Endocrinology, 1977